PulseMedica Raises $12 Million CAD to Advance Eye Floater Imaging and Treatment Technology

EDMONTON, Alberta -- In a significant endorsement of its revolutionary technology, PulseMedica Corp. (“PulseMedica” or the “Company”), a life sciences startup, announced today that it has raised an aggregate of $12 million CAD to date in investment as part of their pre-Series A financing round. This investment allowed PulseMedica to generate exciting initial results from their preclinical and clinical studies and will continue to accelerate the clinical validation of PulseMedica’s innovative floater imaging device. Additionally, the investment supports ongoing laser safety and feasibility studies essential for the first-in-human clinical trial for floater treatment. Funds are also directed toward expanding the technical and business teams in preparation for commercialization and regulatory approvals. Read More